All pharmaceuticals Articles
-
1.1KLatest Myopia NewsFDA Accepts New Drug Application for Sydnexis’ SYD-101
March 11, 2025 DEL MAR, Calif. — The U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for...
-
1.1KLatest Myopia NewsSydnexis Names Perry J. Sternberg CEO
July 16, 2024 DEL MAR, Calif. — Sydnexis has officially named a new Chief Executive Officer and member of the Board of...
-
1.4KLatest Myopia NewsHarrow’s Compounded Atropine Now Available Through ImprimisRx
February 15, 2023 NASHVILLE, Tenn. — U.S. pharmaceutical company Harrow has released its compounded, patent-pending formulas of low-dose atropine. Eye care professionals...